The A*STAR Genome Institute of Singapore (GIS) and 10x Genomics have launched the Target Inference from Spatialomics & Histology Using Multimodal AI & Phenotypes (TISHUMAP) project to accelerate drug discovery for cancer and inflammatory diseases.

• Technical Scope: The study will use spatial biology and AI to analyse up to 2,500 clinical tissue samples, focusing on gastric, liver, and colorectal cancers.
• Methodology: Researchers will utilise the Xenium platform to visualise gene activity within individual cells in intact tissues without breaking them down.
• Application: The project aims to identify novel biomarkers and therapeutic targets to support the future development of personalised treatment plans.

This summary is based on a press release issued by A*STAR GIS.